{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:51:17Z","timestamp":1792637477648,"version":"4.5.0"},"reference-count":21,"publisher":"The Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context:<\/jats:title>\n                    <jats:p>Polycystic ovary syndrome (PCOS) affects 6%\u201321% of women. PCOS has been associated with an increased risk of dysglycemia including gestational diabetes mellitus (GDM) and type 2 diabetes mellitus (T2DM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>The objective of the study was to assess the prevalence of dysglycemia and the impact of obesity in young reproductive-aged women with and without PCOS in a community-based cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>This was a cross-sectional analysis of data from a large longitudinal study (the Australian Longitudinal Study on Women's Health).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting:<\/jats:title>\n                    <jats:p>The setting for the study was the general community.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants:<\/jats:title>\n                    <jats:p>Women were randomly selected from the national health insurance database. Standardized data collection occurred at five survey time points (years 1996, 2000, 2003, 2006, and 2009). Data from survey 4 (2006, n = 9145, 62% of original cohort aged 18\u201323 y) were examined for this study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcome Measures:<\/jats:title>\n                    <jats:p>Self-reported PCOS, GDM, and T2DM were measured.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>In women aged 28\u201333 years, PCOS prevalence was 5.8% [95% confidence interval (CI) 5.3%\u20136.4%]. The prevalence of GDM (in women reporting prior pregnancy) and T2DM was 11.2% and 5.1% in women with PCOS and 3.8% and 0.3% in women without PCOS, respectively (P for both &amp;lt; .001). PCOS was associated with an increased odds of GDM and T2DM. After adjusting for age, body mass index, hypertension, smoking, and demographic factors, the odds of GDM (odds ratio 2.1, 95% CI 1.1\u20133.9, P = .02) and T2DM (odds ratio 8.8, 95% CI 3.9\u201320.1, P &amp;lt; .001) remained increased in women reporting PCOS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>In a large community-based cohort of reproductive-aged women, PCOS was independently associated with a higher risk of GDM and T2DM, independent of body mass index. Aggressive screening, prevention, and management of dysglycemia is clearly warranted in women with PCOS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/jc.2013-2007","type":"journal-article","created":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T02:06:42Z","timestamp":1380593202000},"page":"E447-E452","source":"Crossref","is-referenced-by-count":128,"title":["Gestational Diabetes and Type 2 Diabetes in Reproductive-Aged Women With Polycystic Ovary Syndrome"],"prefix":"10.1210","volume":"99","author":[{"given":"A. E.","family":"Joham","sequence":"first","affiliation":[{"name":"Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, (A.E.J., S.R., S.Z., L.M., H.J.T.), Monash University, and Southern Health, Clayton, Victoria 3168, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ranasinha","sequence":"first","affiliation":[{"name":"Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, (A.E.J., S.R., S.Z., L.M., H.J.T.), Monash University, and Southern Health, Clayton, Victoria 3168, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Zoungas","sequence":"first","affiliation":[{"name":"Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, (A.E.J., S.R., S.Z., L.M., H.J.T.), Monash University, and Southern Health, Clayton, Victoria 3168, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Moran","sequence":"first","affiliation":[{"name":"Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, (A.E.J., S.R., S.Z., L.M., H.J.T.), Monash University, and Southern Health, Clayton, Victoria 3168, Australia"},{"name":"The Robinson Institute (L.M.), University of Adelaide, North Adelaide, SA 5006, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. J.","family":"Teede","sequence":"first","affiliation":[{"name":"Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, (A.E.J., S.R., S.Z., L.M., H.J.T.), Monash University, and Southern Health, Clayton, Victoria 3168, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"issue":"6","key":"2020071613030650900_B1","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2020071613030650900_B2","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","article-title":"The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria","volume":"25","author":"March","year":"2010","journal-title":"Hum Reprod"},{"issue":"1","key":"2020071613030650900_B3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome","volume":"81","author":"Group","year":"2004","journal-title":"Fertil Steril"},{"issue":"7","key":"2020071613030650900_B4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.tem.2007.08.001","article-title":"The management of insulin resistance in polycystic ovary syndrome","volume":"18","author":"Teede","year":"2007","journal-title":"Trends Endocrinol Metab"},{"issue":"8","key":"2020071613030650900_B5","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1210\/jc.2004-1487","article-title":"Vascular dysfunction and metabolic parameters in polycystic ovary syndrome","volume":"90","author":"Meyer","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2020071613030650900_B6","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.molmed.2006.05.006","article-title":"Molecular mechanisms of insulin resistance in polycystic ovary syndrome","volume":"12","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Trends Mol Med"},{"key":"2020071613030650900_B7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1741-7015-8-41","article-title":"Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan","volume":"8","author":"Teede","year":"2010","journal-title":"BMC Med"},{"issue":"3","key":"2020071613030650900_B8","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/humrep\/des463","article-title":"Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp","volume":"28","author":"Stepto","year":"2013","journal-title":"Hum Reprod"},{"issue":"2","key":"2020071613030650900_B9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.5694\/j.1326-5377.1998.tb140192.x","article-title":"Gestational diabetes mellitus\u2014management guidelines. The Australasian Diabetes in Pregnancy Society","volume":"169","author":"Hoffman","year":"1998","journal-title":"Med J Aust"},{"key":"2020071613030650900_B10","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.2337\/dc07-s206","article-title":"Increasing prevalence of gestational diabetes mellitus: a public health perspective","volume":"30","author":"Ferrara","year":"2007","journal-title":"Diabetes Care"},{"issue":"6","key":"2020071613030650900_B11","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dml036","article-title":"A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome","volume":"12","author":"Boomsma","year":"2006","journal-title":"Hum Reprod Update"},{"issue":"4","key":"2020071613030650900_B12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq001","article-title":"Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"16","author":"Moran","year":"2010","journal-title":"Hum Reprod Update"},{"issue":"6","key":"2020071613030650900_B13","first-page":"S65","article-title":"Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline","volume":"195","author":"Teede","year":"2011","journal-title":"Med J Aust"},{"issue":"5","key":"2020071613030650900_B14","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/ije\/dyi098","article-title":"Cohort Profile: The Australian longitudinal study on Women's Health","volume":"34","author":"Lee","year":"2005","journal-title":"Int J Epidemiol"},{"issue":"4","key":"2020071613030650900_B15","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.annepidem.2010.01.002","article-title":"The impact of attrition in an 11-year prospective longitudinal study of younger women","volume":"20","author":"Powers","year":"2010","journal-title":"Ann Epidemiol"},{"issue":"1","key":"2020071613030650900_B16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1300\/J013v28n01_03","article-title":"Women's Health Australia: recruitment for a national longitudinal cohort study","volume":"28","author":"Brown","year":"1998","journal-title":"Women Health"},{"issue":"8","key":"2020071613030650900_B17","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/oby.20213","article-title":"Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women","volume":"21","author":"Teede","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"2020071613030650900_B18","doi-asserted-by":"crossref","first-page":"d6309","DOI":"10.1136\/bmj.d6309","article-title":"Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study","volume":"343","author":"Roos","year":"2011","journal-title":"BMJ"},{"issue":"1","key":"2020071613030650900_B19","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"24","key":"2020071613030650900_B20","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa042973","article-title":"Effect of treatment of gestational diabetes mellitus on pregnancy outcomes","volume":"352","author":"Crowther","year":"2005","journal-title":"N Engl J Med"},{"issue":"19","key":"2020071613030650900_B21","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0707943","article-title":"Hyperglycemia and adverse pregnancy outcomes","volume":"358","author":"Metzger","year":"2008","journal-title":"N Engl J Med"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/99\/3\/E447\/11158142\/jcemE447.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/99\/3\/E447\/11158142\/jcemE447.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T18:51:02Z","timestamp":1594925462000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/99\/3\/E447\/2537327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,1]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2013-2007","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,1]]}}}